Otrivin Adult Nasal Metered-Dose Spray

The effect of Otrivin sets in within a few minutes and persists for several hours. Otrivin Adult Nasal Metered Dose Spray:

Ingredients and Instructions for use

Ingredients: 1 ml contains 1 mg of xylometazoline hydrochloride. Preservative: 0,011 % m/v benzalkonium chloride. Excipients: disodium edetate, disodium phosphate dodecahydrate, methyl hydroxypropyl-cellulose, purified water, sodium chloride, sodium dihydrogen phosphate dihydrate, sorbitol 70 % (non-crystallising).

Otrivin Adult Nasal Drops and Otrivin Adult Nasal Metered-Dose Spray (1 mg/ml) are for nasal administration only, in adults and children over 12 years of age.

2 to 3 drops of the 1 mg/ml solution into each nostril per application, or one puff from the metered-dose spray, into each nostril per application; a total of 3 applications a day is usually sufficient.

How to use Otrivin Adult Nasal Metered-Dose Spray

High Density Polyethylene bottle mounted with a metered-dose pump and a polypropylene nozzle with a protective cap.

Otrivin Adult Metered-dose spray is for nasal administration only, in adults and children over 12 years of age: 1 application of the metered-dose spray into each nostril; a total of 3 applications a day is usually sufficient. Otrivin should be used after blowing the nose.
Safety Information

Otrivin should be used with caution in patients showing a strong reaction to sympathomimetic agents, as evidenced by signs of insomnia, dizziness as manifested by signs of insomnia, dizziness, tremor, cardiac dysrhythmias or elevated blood pressure.

Otrivin should be used with caution in patients with hypertension, cardiovascular disease, hyperthyroidism, diabetes mellitus, epistaxis, phaechromocytoma, prostatic hypertrophy, monoamine oxidase inhibitors (MAOI) treatment or who have received them in the last two weeks (see INTERACTIONS).

Do not exceed the recommended dose, especially in children and in the elderly.

Otrivin should not be used for more than ten consecutive days: prolonged or excessive use may cause rebound congestion and/or atrophy of the nasal mucosa.
How to store Otrivin Adult Nasal Metered-Dose Spray

Store at or below 25 °C. Keep out of the reach of children. Do not use the product after the expiry date shown on the packaging.

Promotion of Access to Information Act (PAIA)

The PAIA manual is prepared in accordance with section 51 of the Promotion of Access to Information Act (PAIA) No. 2 of 2000 (as amended) and the Protection of Personal Information Act, 2013. The purpose of PAIA is to promote the right of access to information, to foster a culture of transparency and accountability within the Company by giving the right to information that is required for the exercise or protection of any right and to actively promote a society in which the people of South Africa have effective access to information to enable them to exercise and protect their rights.

Please see the PAIA manual.

S1 Otrivin Adult Drops. Each 1 ml contains 1 mg of xylometazoline hydrochloride. Preservative: benzalkonium chloride 0.01 % m/v. Reg. no.: H/16.1/1382.
S1 Otrivin Adult Nasal Metered-dose Spray. Each 1 ml contains 1 mg of xylometazoline hydrochloride. Preservative: benzalkonium chloride 0.01 % m/v. Reg. no.: H/16.1/1382.

* class-specific comparison (topical vs systemic decongestant)

Ref 1. Eccles R. Over the counter medicines for colds. In: Common Cold. Eccles R & Weber O, eds. Basel, Switzerland: Birkhäuser Verlag; 2009. (see reference here)

Ref 2. Eccles R, Eriksson M, Garreffa S, et al. The nasal decongestant effect of xylometazoline in the common cold. Am J Rhinol. 2008;22(5):491–6 (see reference here)

S1 OTRIVIN Menthol Nasal Metered-dose Spray. Each 1 ml contains 1 mg of xylometazoline hydrochloride. Preservative: benzalkonium chloride 0.01% m/v. Reg. no.: 31/16.1/0319.
S1 OTRIVIN Paed. Drops. Each 1 ml contains 0,5 mg of xylometazoline hydrochloride. Preservative: benzalkonium chloride 0.01 % m/v. Reg. no.: H/16.1/1381.
S1 OTRIVIN Paed. Nasal Metered-dose Spray. Each 1 ml contains 0, 5 mg of xylometazoline hydrochloride. Preservative: Benzalkonium chloride 0.01 % m/v. Reg. no.: H/16.1/1381.

Applicant: Haleon South Africa (Pty) Ltd. 11 Hawkins Avenue, Epping Industria 1, Cape Town,7450.

Company reg. no.: 2014/173930/07. For full prescribing information refer to the professional information approved by the medicines regulatory authority Always read label prior to use.

For any further information, including safety and adverse reactions, please contact the Haleon Hotline on 0800 007 018 or mystory.za@haleon.com.

This website is intended for residents of South & Southern African residents only.

* We do not supply our products directly to consumers. By selecting the Buy Now*/Try Now button on this page, you will be re-directed to a list of retailers’ websites for purchase. Kindly note that purchase will be subject to stock availability.

PM-ZA-OTRI-21-00023